Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples